Shares of MediWound Gained 23% in First Day of Trading

Shares of MediWound MDWD jumped 23 percent to $17.27 in its first day of trading. Shares opened at 10:25 a.m. EDT on Thursday for $16 per share. The company raised $70 million after five million shares were priced at $14, the lower end of the initial range of $14-$16. Credit Suisse, BMO Capital, and Jefferies were the lead underwriters for the offering. MediWound is a fully-integrated biopharmaceutical company focused on developing, manufacturing and commercializing novel products to address unmet needs in the fields of severe burns, chronic and other hard-to-heal wounds and connective tissue disorders.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsIPOsand JefferiesBMO CapitalCredit Suissi
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!